Indication
Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
1 clinical trial
1 product
Clinical trial
An Open, One-arm, Prospective Study of a Single Dose Anti-CD20 Monoclonal Antibody Combined With Bortezomib for Treatment of Relapsed Refractory Autoimmune Hemolytic AnemiaStatus: Completed, Estimated PCD: 2024-03-01